5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.
US Stocks dipped ahead of Nvidia earnings but a few sent retailers into a tizzy.
US Stocks dipped ahead of Nvidia earnings but a few sent retailers into a tizzy. | Photo Courtesy of Wikimedia Commons
Profile Image
Shanthi M·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...

The market’s resilience came under test on Wednesday as apprehensions ahead of earnings from artificial intelligence stalwart Nvidia Corp. ($NVDA) generated some weakness early in the session.

Nvidia stock was last seen trading down more than 1%, giving back some of the nearly 5% gain it made on Wednesday.

As traders look ahead to the company’s market-moving earnings report, due after the market close, here is a compilation of the most bullish stocks on Stocktwits:

Read Next
Loading...
Loading...

Advertisement|Remove ads.

Forte Biosciences, In. ($FBRX

Forte Biosciences shares were last seen rallying over 170% as the nano-cap autoimmune disorders-focused clinical-stage biopharma said its equity financing to support the continuing clinical advancement of its lead candidate FB102 was oversubscribed. “ As a result of the financing, Forte is well capitalized to continue advancing FB102 across autoimmune indications,” it added.

Quantum-Si Inc. ($QSI):

Advertisement|Remove ads.

Shares of Quantum-Si, a medical-device company that develops a single-molecule detection platform to enable next-gen protein sequencing (NGPS), more than doubled on Wednesday on volumes that are notably above their 3-month average.

The upside came after the company made a slew of announcements. Quantum-Si said Avantor, Inc. ($AVTR) will distribute its NGPS portfolio, providing researchers across the U.S. and Canada access to the portfolio.

In a separate release, Quantum-Si announced a collaboration with Nvidia to develop its next proteomics platform called Proteus and advance its core technologies of amino acid binders and amino peptidases using Nvidia AI and accelerated computing. 

Advertisement|Remove ads.

Quantum-Si also announced an expanded partnership with SkyWater Technology, Inc. ($SKYT) for developing Proetus and a separate deal with its contract manufacturing partner Planet Innovation for the same. 

Silexion Therapeutics Corp. ($SLXN)

Silexion, a clinical-stage biotech developing RNA interference therapies for certain types of cancers, disclosed in a filing on Tuesday that at the reconvened extraordinary general meeting, its shareholders approved the board recommendation for a reverse split of the shares in the ratio 1-for-9. 

Advertisement|Remove ads.

The penny stock climbed 33% on Wednesday on above-average volume.

Duos Technologies Group, Inc. ($DUOT)

Shares of Jacksonville, Florida-based Duos Tech, a software services provider, climbed over 17% after the company announced the signing of a $42 million worth of asset management agreement with Fortress Investment Group to deploy and operate a fleet of mobile gas turbines and balance-of-plant inventory that has a combined generation capacity of 850 megawatts.

Advertisement|Remove ads.

ZIM Integrated Shipping Services Ltd. ($ZIM)

Cargo shipping firm ZIM Integrated reported upbeat third-quarter earnings and raised its full-year guidance, sending its shares higher by over 7%. Retail hoped for large buyers increasing their exposure to the stock, sending it to the $31-$32 area by the close.

Advertisement|Remove ads.

For updates and corrections email newsroom@stocktwits.com 

Read Next: Nvidia Stock Slips Ahead Of Earnings: Gene Munster Explains Why Blackwell Chip Demand Commentary Is Important For Investors

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.